Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma Glenmark gets USFDA nod for psoriasis drug
The approved product is a generic version of Olux-E Foam, 0.05 per cent. GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam,0.05% (Emulsion Formulation) Glenmark Pharmaceuticals Ltd - 532296 - Reg. 34 (1) Annual Report
Submission of Annual Report under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Glenmark Pharmaceuticals Ltd - 532296 - Notice Of 41St Annual General Meeting Of The Company For FY 2018-19 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Further to our letter dated 23 August, 2019, enclosed please find herewith the Notice Convening the 41st Annual General Meeting of the Company scheduled to be held on Friday, 27 September, 2019 for your information and record. Company news: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals on Friday said it has received final approval from the USFDA for Pimecrolimus cream, used to treat skin conditions such as ec Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Pimecrolimus Cream, 1% GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Pimecrolimus Cream, 1% Glenmark recalls 31,000 tubes of anti-fungal cream from US market
Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the United States (US) mar GLENMARK PHARMACEUTICALS LTD. - 532296 - Intimation Of The Date Of 41St Annual General Meeting And Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We have to inform you that the 41st Annual General Meeting (AGM) of Members of the Company is scheduled to be held on Friday, September 27, 2019 at 11.00 a.m. at Sunville Banquets & Conference Hall, 3rd floor, Dr. Annie Besant Road, Worli, Mumbai - 400 018. The copy of the notice will be sent to you in due course. Pursuant to the Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and the Share Transfer Books of the Company will remain closed from Saturday, September 21, 2019 to Friday, September 27, 2019 (both days inclusive) for the purpose of the AGM and determining the names of the eligible Members for equity dividend. The dividend, if approved by the Members at the ensuing AGM, will be paid on or after October 1, 2019.